Drug profile · INN
amphotericin b
AMPHOTERICIN B
- US status
- approved
- Patents linked
- 1
- News articles
- 0
Quick answer
amphotericin b (AMPHOTERICIN B) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: topical. Current US regulatory status: approved.
Key facts
INN amphotericin b
Brand AMPHOTERICIN B
Route TOPICAL
Formulation INJECTABLE, LIPOSOMAL
Originator Teva Pharma GmbH
Related patents
Search patents →Frequently asked questions
What is amphotericin b?
amphotericin b (AMPHOTERICIN B) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for amphotericin b?
AMPHOTERICIN B is a marketed brand name for amphotericin b. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of amphotericin b?
amphotericin b has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.